NDC 83301-0005-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83301-0005
- Requested NDC
- 83301-0005-01
- Package NDCs from labels
- 83301-0005-1, 83301-0005-2, 83301-0005-3, 83301-0005-01
- Manufacturer
- Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd
- Effective date
- 2025-08-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd | Mullan Pharmaceutical Inc. | CSPC Ouyi Pharmaceutical Co., Ltd | 2025-08-21 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83301-0005-1 | Gabapentin | 100 in 1 BOTTLE, PLASTIC | CAPSULE | 100 | 10 | |
| 83301-0005-2 | Gabapentin | 500 in 1 BOTTLE, PLASTIC | CAPSULE | 500 | 10 | |
| 83301-0005-3 | Gabapentin | 1000 in 1 BOTTLE, PLASTIC | CAPSULE | 1000 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 83301-0005 | GABAPENTIN CAPSULE [MULLAN PHARMACEUTICAL INC.] | 9 | Current NDC, 3 package rows | 20250411_74474aa4-4859-42d2-92d8-f23f18b34e04.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 83301-0005-1 | EA - Each | 83301-0005 | 8863e540-5809-485e-b28f-833f840df39d | 1 | 2025-07-08 |
| 83301-0005-2 | EA - Each | 83301-0005 | 2fdf46c8-044b-4fb6-8496-b200e820e40c | 1 | 2025-07-08 |
| 83301-0005-3 | EA - Each | 83301-0005 | fbdbf58f-5483-478d-b070-ffd9ed22778b | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Sepia | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 418cdd4a-23f7-4181-b734-5ab7456494a2 | 2021-06-29 | Warnings | 15FIX9V2JP |
| No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Toffee | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 50138c51-f424-4b07-b3eb-c0d31d8ecf16 | 2021-06-29 | Warnings | 15FIX9V2JP |
| No7 Protect and Perfect Intense Advanced All in One Foundation SPF 50 Cameo | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 01a861b9-0ab6-4c4c-a407-428a64509a1c | 2021-06-29 | Warnings | 15FIX9V2JP |
| No7 Protect and Perfect Intense Advanced All in One Foundation SPF 50 Birch | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | d5431d62-fded-4cdc-81a1-5b5e3eb92873 | 2021-06-29 | Warnings | 15FIX9V2JP |
| No7 Protect and Perfect Intense Advanced All in One Foundation SPF 50 Tawny | OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE | BCM Cosmetique SAS | 52c3378f-6b99-42fa-900e-8a693864c615 | 2021-06-29 | Warnings | 15FIX9V2JP |
| Gabapentin | GABAPENTIN | Amneal Pharmaceuticals of New York LLC | b11dbff5-ceee-4a63-a093-f6efebdc2f6f | 2021-02-03 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | f6baeb5c-ca9c-4730-aeb8-8f8732e8ca3a | 2021-01-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | c79d94ec-117d-4fb6-845d-1954e3472bb0 | 2021-01-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gaba 300-EZS | GABAPENTIN | PureTek Corporation | bb29692e-1546-4d05-a46a-93baf4172c7d | 2020-11-16 | Warnings, Adverse reactions | 310431 |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 3b4395f2-9440-4b67-97cc-5d16f3bdd05e | 2020-08-14 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | 39149f0e-30ed-4671-8be7-2a484f65d63b | 2020-08-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | ded42b88-94dd-462d-bcdf-7fd34d1e49c3 | 2020-07-01 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Asclemed USA, Inc. | 45039bba-7a96-450c-95be-83a3aa4fcbd2 | 2020-06-10 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 8b2f38ef-0a0c-45cc-88ca-cc086bf80641 | 2020-06-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Aphena Pharma Solutions - Tennessee, LLC | ba2a8352-5776-4edb-914e-ce1d18ccda32 | 2020-05-27 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | c09c66fd-cb31-41dd-b00b-acc58bd809f7 | 2020-01-01 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 7d77dae0-df76-4b7b-9690-713e9a60e3cd | 2019-12-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | 4bae5032-f634-4d1e-b672-8a7e2bd6a5fa | 2019-11-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Proficient Rx LP | 92c4d589-533b-4fe4-833f-dd68cc1f7e66 | 2019-11-01 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Proficient Rx LP | 2ef99c3d-866a-438b-a340-8beba8d4c457 | 2019-11-01 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.